Sernova Presents Positive Preliminary Safety and Efficacy Data in its Phase I/II Clinical Trial for Type-1 Diabetes

Sernova’s Cell Pouch (TM) with transplanted islet cells reached primary safety measurements and clinically significant efficacy outcomes including glucose-stimulated C-peptide and the release of insulin in the first patient transplanted  Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF), a clinical-stage regenerative medicine company today announced that in an interim analysis of its human Phase I/II clinical trial, Sernova’s Cell Pouch…

Sernova to Present Interim Data from Ongoing Phase I/II Cell Pouch Clinical Trial at the 17th World Congress of the International Pancreas and Islet Transplant Association

Sernova Corp. (TSX-V:SVA)(OTCQB:SEOVF), a clinical-stage regenerative medicine company is pleased to announce that Dr. Piotr Witkowski, Director of Pancreatic, and Islet Transplant Program at the University of Chicago, will present, in an oral podium session, early preliminary data and observations from Sernova’s ongoing clinical trial, entitled A Safety, Tolerability and Efficacy Study of Sernova’s Cell…

TechAlliance announces the 2019 60-Second Pitch winners

On Thursday, June 13, TechAlliance held our biennial 60-Second Pitch Competition & Awards Celebration at Voices.com. The evening showcased a roster of exciting and diverse tech companies pitching in hopes of claiming their share of the prize pool valued at a total of almost $50,000 worth of business acceleration resources to help their ventures grow.…

BURST Feature: ONPoint Medical & Tune-OUT Medical

Meet two companies represented in the fourth cohort of TechAlliance’s BURST program. We sat down with Western Medical Innovation Fellowship‘s most recent alumni Dr. Maryanne Siu, Dr. Jacob Reeves, Dr. Mahmoud Ramin, Bartosz Slak and Dr. Ibrahim Marwa to discuss their two BURST-supported companies, ONPoint Medical Inc. and Tune-OUT Medical Inc. and the combined $140,000…

Sernova Announces Collaboration to Advance Therapeutic Cell Pouch Technologies for the Treatment of Hypothyroidism

Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF), a clinical- stage regenerative medicine company announced today a collaboration with the University of British Columbia’s, Dr. Sam Wiseman for development of a Cell Therapy-based Program for the treatment of hypothyroidism. This collaboration is funded by a Transplant Venture Grant awarded by the Transplant Research Foundation (TRF) of British…

Renix Successfully Commissions the Demonstration RenixUIX™ Unit

Renix understands the need to provide cost-effective and sustainable solutions to capture, separate, and purify resources for the increasing needs of the global population. The world’s producers and providers need these solutions to face the looming technical and economic pressures associated with lower grade sources, increased regulation, and increased environmental and social licensing issues. As…

Four London Companies Rank Deloitte’s Technology Fast 500

This morning, we’re very happy to announce that four London companies were ranked on Deloitte’s Technology Fast 500. Congratulations to Voices.com, Diply, Arcane, and Big Viking Games! Check out the full list here. Voices.com Ranked Number 288 on Deloitte’s 2018 Technology Fast 500™ Voices.com​, the largest global online marketplace for voice over, today announced it has ranked…